Three papers in Current Eye Research have apparently not quite lived up to the journal’s name. The journal in November retracted three studies from a group of authors in China who had previously published the papers in their native language.
Here’s the notice, which also appears in this month’s print edition: Continue reading Seeing double: Current Eye Research retracts three papers for duplication
Earlier this year we reported on the case of Bernardino Saccomanni, an apparently shameless plagiarist with a fondness for publishing in the orthopedics literature.
Somehow, we’re not surprised to learn that Saccomanni may not have been totally above board in other ways, too.
According to Robert Lindsay, editor of Osteoporosis International, whose journal has retracted one of Saccomanni’s plagiarized manuscripts, the researcher’s stated affiliation on several recent papers — Gabriele D’ Annunzio University Chieti — had long ago severed ties with him: Continue reading Orthopedics plagiarist may have lied about affiliation
Last week, we brought you the tale of a paper about camels that was rejected on submission, but published accidentally, and then retracted. It turns out this was not a unique occurrence.
An eagle-eyed Retraction Watch reader emailed us about another such paper, this one in the Journal of Nanoparticle Research. The study, “Growth of gold flowers on polyacrylonitrile fibers,” appears to have been published online on December 3, 2008. It now sports this retraction notice: Continue reading Another paper rejected, mistakenly published, then retracted, this one in nanotechnology journal
Many Retraction Watch readers will now be familiar with the case of Dipak Das, the resveratrol researcher about whom the University of Connecticut issued a voluminous report yesterday — summary here — detailing 145 counts of data fabrication and falsification. This has been a fast-moving story, so we wanted to highlight a number of updates to our original post, and offer a few more.
First, we have confirmed with publisher Mary Ann Liebert this morning that Das has been relieved of his duties as co-editor in chief of Antioxidants & Redox Signaling. He had shared that post with Chandan Sen, and his name as been removed from the masthead of that journal. Here’s a statement from the publisher: Continue reading Resveratrol fraud case update: Dipak Das loses editor’s chair, lawyer issues statement refuting all charges
If there’s one thing worse than having your paper rejected by a journal, it’s having it retracted. But usually a paper has to be accepted before it’s published and withdrawn.
Not so for a study from the United Arab Emirates, “Detection and genotyping of GB virus-C in dromedary camels in the United Arab Emirates,” published in 2010 in Veterinary Microbiology.
The editors of the journal ruminated — hey now! is this thing on? — on the paper, only to give it the thumbs down. But come to find out, it got published anyway. Thus, the following retraction notice, which appeared online last month: Continue reading Eye of the needle? Paper about camels gets rejected, then published, then retracted
The journal Cancer has issued an Expression of Concern about two lung cancer screening papers long dogged by doubt.
Last April, The Cancer Letter and The New York Times jointly published an investigation into the International Early Lung Cancer Action Program (I-ELCAP) run by Claudia Henschke and David Yankelevitz. Other researchers had already criticized the design and conclusions of that trial, but as the investigation noted, an October 2008 review of the study found that the researchers couldn’t find 90 percent of the subjects’ consent forms, an ethical no-no that jeopardizes as many as 135 papers.
Two papers published in Cancer, in 2000 and 2001, are among those studies, according to the notice (links added), which credits the Times and The Cancer Letter and notes that the journal has referred the case to Federal investigators: Continue reading Cancer issues expression of concern about two Henschke I-ELCAP lung cancer screening papers
The authors of a study in Urology that was at the center of two 2009 lawsuits brought by a company that funded the work have retracted the paper.
The idea behind the research — by Robert Getzenberg and colleagues at Johns Hopkins — was to find an alternative to the prostate specific antigen (PSA) test, which many urologists recommend, but which many groups — including the US Preventive Services Task Force — find wanting. The work gave rise to a company, Onconome, Science reported in a 2009 story about the lawsuits: Continue reading Hopkins scientists retract prostate cancer screening study at center of 2009 lawsuits
The January 2012 issue of Biosystems Engineering has a commendably thorough retraction notice regarding a case of plagiarism in its pages.
The notice, regarding the article “Advanced techniques for Weed and crop identification for site specific Weed management,” by Karan Singh, K.N. Agrawal, and Ganesh C. Bora, of North Dakota State University, speaks for itself: Continue reading Plagiarism kills weed paper
Several journals in the field of orthopedics and related disciplines have been victimized by an apparent serial plagiarist.
The author, Bernardino Saccomanni, of Gabriele D’ Annunzio University, in Chieti Scalo, Italy—across the boot and up a bit from Rome—appears to have lifted significant amounts of text in several articles.
Last January, for example, Current Reviews in Musculoskeletal Medicine, a Springer title, retracted a 2010 article by Saccomanni, “Painful os intermetatarseum in athletes: a literature review of this condition is presented,” after determining that it plagiarized a 2007 article in the Archives of Orthopaedic Trauma Surgery, also from Springer, with a very similar title, “Painful os intermetatarseum in athletes: report of four cases and review of the literature.”
Osteoporosis International, another Springer publication, has retracted a 2011 paper by Saccomanni titled “Vertebroplasty: an international point of view on this “minimally invasive” surgical technique,” after evidently learning that the point of view wasn’t exactly Saccomanni’s to begin with. Continue reading Multiple retractions as brazen plagiarist victimizes orthopedics literature
Another paper in Diabetologia by Yoshiyuki Hattori has been retracted for image duplication, marking the second of his articles in the journal to be pulled for that reason.
The notice for the article, “A glucagon-like peptide-1 (GLP-1) analogue, liraglutide, upregulates nitric oxide production and exerts anti-inflammatory action in endothelial cells,” states: Continue reading Another Hattori retraction over reused figure from cardiology pub